EBD GmbH is part of the Knowledge & Networking Division of Informa PLC


This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa
 
BioPharm America 2014 EBD Group MassBio
Share/Follow Us
Share this:
Follow this event:
Follow us on Twitter
Subscribe to our newsletters:

BioPharm America™ 2015 Press Releases

September 2, 2015EBD Group to announce the Johnson & Johnson Innovation Startup Day competition grand prize winner at BioPharm America™ 2015 Partnering EventLeaders in life sciences to gather in Boston September 15–17 for partnering event
September 2, 2015: BioPharm America 2015 life science partnering event will take place in Boston September 15–17 at the Boston Marriott Copley Place. The event will convene members of the global life science community to forge connections among startups, entrepreneurs and the drug development industry. A pitch contest for startup and young companies will take place in ...  more ►

July 22, 2015BioPharm America™ 2015 to bring industry heavy hitters and biotech disruptors to Boston September 15–17 BioPharm America 2015 will once again bring the most talented, innovative leaders of biotech and pharma to Boston this September 15–17 at the Boston Marriott Copley Place. An increasing number of industry heavy hitters have successfully led and exited large corporations and are now investing their experience, clout and personal finances to reseed the life science ecosy...  more ►

June 9, 2015Spotlight on Boston Business Facts The life sciences corridor in Massachusetts combines the cities of Somerville, Cambridge, Boston, Quincy and Braintree, and is home to over 450 companies within the life science industry cluster. There were USD 1,802 billion of venture investments in Massachusetts biotechs in 2014. Massachusetts has seen 30 companies go public in the last two years. Some of the largest bio...  more ►

May 20, 2015Engage and De-Risk: BioPharm America™ 2015 draws life science dealmaking ecosystem to Boston this September 15–17 EBD Group and MassBio present the eighth annual BioPharm America international life science partnering conference September 15–17 at Boston Marriott Copley Place in the center of Boston's historic Back Bay. The event brings executives from the life science ecosystem together to de-risk the environment inherent to biotech and engage in disruptive dealmaking. BioPharm Am...  more ►



partnering360:Insight Latest headlines from partnering360:Insight

August 29, 2015 HSCI fosters broad collaboration At the Harvard Stem Cell Institute (HSCI), "Partnering is important at all levels," emphasized Brock Reeve, executive director. That impetus is important not just in the sciences, but also among foundations, large and small companies and investors throughout the life sciences community. more ►

August 29, 2015 RA Capital: Flexibility builds innovation Flexibility is the watchword for investment at RA Capital Management. As Peter Kolchinsky, managing director, explained, "Investors should be as flexible as possible. Therefore, we're a crossover fund manager. We invest in biotechnology companies whether they are public or private companies and, increasingly, are putting our efforts into company formation." more ►

August 28, 2015 EBD partnering data dissected If you have attended any of our events, such as BIO-Europe┬«, then you know that they are a hive of partnering activity. Deals are plotted, shaped and consummated as thousands of executives shuttle between one-to-one meetings. If you are like us, then you are probably wondering which companies from what sector are getting the most attention.To get some answers, we asked IMS Health Capital (IMSHC), the investment banking arm of IMS Health, to analyze partnering data from our most recent conferences. more ►

August 8, 2015 Johnson & Johnson Innovation aims for disruption Johnson & Johnson Innovation, Boston, has high expectations for itself and its partners. "We're looking for ideas that will make a tremendous difference in patients' lives, not merely incremental progress," said Robert G. Urban, PhD, head of Johnson & Johnson Innovation, Boston. To do that, "we take advantage of the deep science emerging around us to develop bold platforms that make a big difference. more ►

July 21, 2015 Patient-centric Baxalta capitalizes on Cambridge When Baxalta Incorporated spun out of Baxter on July 1, it already qualified as "big pharma." With USD 6 billion in annual revenues, 16,000 employees, operations in 100 countries and USD 600 million invested in R&D, it focuses its assets tightly on the patient experience and expects its partners to do the same. more ►



Arrow Up


 
 

Follow this event: Follow us on Twitter
Sign up now
For news and updates

Privacy Policy and Cookies Terms of Use

See more upcoming conferences ►

EBD Group's Family of Events

© 2009–2015 EBD Group, Inc.
Privacy Policy and Cookies
Terms of Use